Nuvation Bio Q4 EPS $(0.10) Beats $(0.11) Estimate

Nuvation Bio (NYSE:NUVB) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 16.67 percent increase over losses of $(0.12) per share from the

Nuvation Bio (NYSE:NUVB) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 16.67 percent increase over losses of $(0.12) per share from the same period last year.

Total
0
Shares
Related Posts
Read More

Here’s Where To Buy Legal Weed: Florida’s Thriving Cannabis Landscape And More New Marijuana Stores In US And Canada

In anticipation of the outcome of Florida's Measure 3, cannabis giants are racing to bolster their retail footprint statewide. In California, four new cannabis stores kicked off sales recently. New York's cannabis retail footprint continues to grow. Five states each opened a new cannabis store, while Canna Cabana retail presence expands in Canada,

CSE:GTII